Skip to main content
. 2021 Oct 14;11:20402. doi: 10.1038/s41598-021-99908-3

Table 1.

The severity of adverse drug reactions was different in patients with different characteristic.

Variables Total N (%) Nonserious N (%) Serious N (%) P value Effect size (φ)
Total 394,037 (100) 358,295 (90.90) 35,742 (9.10)
Age (years)
0–6 22,579 (5.73) 20,888 (92.51) 1691 (7.49)  < 0.001 0.560
6–18 15,970 (4.05) 14,718 (92.16) 1252 (7.84)
18–35 56,365 (14.30) 52,659 (93.42) 3706 (6.58)
35–60 156,059 (39.61) 142,930 (91.59) 13,129 (8.41)
60–80 124,068 (31.48) 110,619 (89.16) 13,449 (10.84)
 > 80 18,640 (4.73) 16,468 (88.35) 2172 (11.65)
Missing 356 (0.10)
Gender
Male 187,473 (47.58) 170,404 (90.90) 17,069 (9.10) 0.496 -0.001
Female 206,042 (52.29) 187,411 (90.96) 18,631 (9.04)
Missing 522 (0.13)
Hospital level
Unrated 31,497 (7.99) 30,416 (96.57) 1081 (3.43) < 0.001 0.119
1 139,307 (35.35) 130,172 (93.44) 9135 (6.56)
2 138,480 (35.14) 125,431 (90.58) 13,049 (9.42)
3 84,753 (21.50) 72,276 (85.28) 12,477 (14.72)
Medication method
Oral 165,060 (41.89) 159,655 (96.72) 5405 (3.27) < 0.001 0.180
Injection 218,327 (55.41) 188,392 (86.29) 29,935 (13.71)
Others 10,650 (2.70) 10,248 (96.23) 402 (3.77)
Type of drug
Chemical compound 302,078 (76.66) 273,904 (90.67) 28,174 (9.33) < 0.001 0.410
Chinese patent medicine 72,218 (18.33) 66,777 (92.47) 5441 (7.53)
Imported and biologics 12,163 (3.09) 10,415 (85.63) 1748 (14.37)
Past history
No 257,061 (65.24) 233,255 (90.74) 23,806 (9.26) < 0.001 0.570
Yes 5922 (1.50) 4648 (78.49) 1274 (21.51)
Unknown 131,054 (33.26) 120,392 (91.86) 10,662 (8.14)
ADRs occurrence
First 387,642 (98.38) 352,672 (90.98) 34,970 (9.02) < 0.001 0.013
Again 6395 (1.62) 5623 (87.93) 772 (12.07)
New ADRs
Yes 101,727 (25.82) 91,208 (89.66) 10,519 (10.34) < 0.001 0.026
No 292,310 (74.18) 267,087 (91.37) 25,223 (8.63)